FindTrial
Sign In

A retrospective study for treatment of prophylactic angiographic embolisation in Forrest IIa ulcer

A retrospective study for risk factors of rebleeding and comparison between different hemostatic therapies in gastrointestinal bleeding patients with Forrest IIa ulcer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025975
Enrollment
Unknown
Registered
2019-09-16
Start date
2019-09-19
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer

Interventions

p-TAE group:p-TAE+endoscopy
Control group:Endoscopy without p-TAE

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Forrest IIa ulcer under endoscopy.

Exclusion criteria

Exclusion criteria: 1. Did not receive any hemostatic therapy under endoscopy; 2. Bore the endoscopic appearance of tumor, or were confirmed as tumor by pathology.

Design outcomes

Primary

MeasureTime frame
Rebleeding occurence and time;—

Countries

China

Contacts

Public ContactHuan Tong

West China Hospital, Sichuan University

doctortonghuan@163.com+86 28 85422383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026